SEEBRI
DEAD

Serial Number

86028642

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Aug 5, 2013

Add to watchlist:

No watchlists yet
View on USPTO

SEEBRI Trademark

Serial Number: 86028642

SEEBRI is a trademark filed by NOVARTIS AG on August 5, 2013. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

August 5, 2013

Registration Date

Not Registered

Published for Opposition

December 17, 2013

Goods & Services

Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Mar 20, 2017 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Mar 20, 2017 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 19, 2016 EXRA
SOU EXTENSION 5 GRANTED
Aug 18, 2016 EX5G
SOU EXTENSION 5 FILED
Aug 7, 2016 EXT5
SOU TEAS EXTENSION RECEIVED
Aug 7, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 13, 2016 EXRA
SOU EXTENSION 4 GRANTED
Feb 12, 2016 EX4G
SOU EXTENSION 4 FILED
Feb 9, 2016 EXT4
SOU TEAS EXTENSION RECEIVED
Feb 9, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 19, 2015 EXRA
SOU EXTENSION 3 GRANTED
Aug 18, 2015 EX3G
SOU TEAS EXTENSION RECEIVED
Aug 4, 2015 EEXT
SOU EXTENSION 3 FILED
Jun 4, 2015 EXT3
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 24, 2015 EXRA
SOU EXTENSION 2 GRANTED
Mar 23, 2015 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 21, 2015 AITU
SOU EXTENSION 2 FILED
Feb 6, 2015 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 6, 2015 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 12, 2014 EXRA
SOU EXTENSION 1 GRANTED
Aug 8, 2014 EX1G
SOU EXTENSION 1 FILED
Aug 8, 2014 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 8, 2014 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 11, 2014 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 17, 2013 NPUB
PUBLISHED FOR OPPOSITION
Dec 17, 2013 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 27, 2013 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 8, 2013 CNSA
ASSIGNED TO EXAMINER
Nov 7, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 12, 2013 NWOS
NEW APPLICATION ENTERED
Aug 8, 2013 NWAP